ROCCA, STEFANIA
 Distribuzione geografica
Continente #
NA - Nord America 404
EU - Europa 239
AS - Asia 182
SA - Sud America 5
AF - Africa 3
Totale 833
Nazione #
US - Stati Uniti d'America 403
IT - Italia 95
CN - Cina 75
SG - Singapore 66
AT - Austria 24
FR - Francia 23
IE - Irlanda 20
DE - Germania 18
SE - Svezia 18
JP - Giappone 12
VN - Vietnam 12
UA - Ucraina 11
FI - Finlandia 10
PL - Polonia 8
ID - Indonesia 7
BR - Brasile 5
NL - Olanda 5
GB - Regno Unito 4
KR - Corea 3
MY - Malesia 3
AM - Armenia 1
CZ - Repubblica Ceca 1
EG - Egitto 1
GR - Grecia 1
HK - Hong Kong 1
IN - India 1
IQ - Iraq 1
MX - Messico 1
RO - Romania 1
SN - Senegal 1
ZA - Sudafrica 1
Totale 833
Città #
Chandler 55
Torino 44
Singapore 43
Beijing 40
Santa Clara 29
Vienna 24
Fairfield 21
Dublin 20
Villeurbanne 16
Woodbridge 16
Dearborn 15
Seattle 15
Ashburn 14
Cambridge 14
Houston 14
Jacksonville 14
Pisa 14
Wilmington 13
Nyköping 12
Ann Arbor 11
Turin 11
Columbus 8
Dong Ket 8
Medford 8
Warsaw 8
Jakarta 7
Princeton 6
Düsseldorf 5
Fremont 5
Silver Spring 5
Nanjing 4
Shanghai 4
Chengdu 3
Fuzhou 3
Hefei 3
Heidelberg 3
Kunming 3
Los Angeles 3
San Mateo 3
Baldissero Torinese 2
Boston 2
Cincinnati 2
Gravina In Puglia 2
Guangzhou 2
Helsinki 2
Kuala Lumpur 2
Lexington 2
Munich 2
Nanchang 2
Nuremberg 2
Paris 2
Tampa 2
Zhangjiagang 2
Atlanta 1
Berlin 1
Bucharest 1
Buffalo 1
Candelária 1
Cape Town 1
Chatham 1
Edinburgh 1
Erbil 1
Frankfurt am Main 1
Grottaglie 1
Hong Kong 1
Jinan 1
Lauterbourg 1
London 1
Lubbock 1
Macerata 1
Martuni 1
Olomouc 1
Phoenix 1
Praia Grande 1
Pune 1
Redwood City 1
Rio das Ostras 1
San Diego 1
Secaucus 1
Suzhou 1
Taubaté 1
Tokyo 1
Upper Marlboro 1
Valparaíso de Goiás 1
Verquières 1
Vigliano Biellese 1
Yantai 1
Totale 606
Nome #
The double face of Morgana in tumorigenesis 176
The IKK/NF-κB signaling pathway requires Morgana to drive breast cancer metastasis 154
Targeting few to help hundreds: JAK, MAPK and ROCK pathways as druggable targets in atypical chronic myeloid leukemia 150
ALTERNATIVE SPLICING VARIANT COULD BE RESPONSIBLE OF MORGANA UNDER-EXPRESSION IN ACML 124
Modeling myeloproliferative neoplasms: From mutations to mouse models and back again 111
ROCK AS THERAPEUTICAL TARGET FOR MORGANA LOW CML 109
miR-15a targets the HSP90 co-chaperone Morgana in chronic myeloid leukemia 34
Totale 858
Categoria #
all - tutte 2.520
article - articoli 0
book - libri 0
conference - conferenze 689
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.209


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202011 0 0 0 0 0 0 0 0 0 0 7 4
2020/202179 6 5 6 2 7 2 2 7 12 8 5 17
2021/202285 6 2 2 10 1 7 6 0 0 12 24 15
2022/2023138 12 17 1 13 16 29 5 14 20 2 5 4
2023/202446 4 9 2 0 2 5 0 9 0 6 3 6
2024/2025171 7 14 16 14 37 19 6 7 32 16 3 0
Totale 858